vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Legacy Housing Corp (LEGH). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $25.5M, roughly 1.8× Legacy Housing Corp). Legacy Housing Corp runs the higher net margin — 32.2% vs -19.9%, a 52.1% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -30.6%). Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -9.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.
ABCL vs LEGH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $25.5M |
| Net Profit | $-8.9M | $8.2M |
| Gross Margin | — | 26.4% |
| Operating Margin | -63.7% | 40.4% |
| Net Margin | -19.9% | 32.2% |
| Revenue YoY | 788.4% | -30.6% |
| Net Profit YoY | 73.9% | -43.5% |
| EPS (diluted) | $-0.03 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $25.5M | ||
| Q3 25 | $9.0M | $28.8M | ||
| Q2 25 | $17.1M | $38.4M | ||
| Q1 25 | $4.2M | $24.3M | ||
| Q4 24 | $5.0M | $36.7M | ||
| Q3 24 | $6.5M | $30.2M | ||
| Q2 24 | $7.3M | $31.7M | ||
| Q1 24 | $10.0M | $30.8M |
| Q4 25 | $-8.9M | $8.2M | ||
| Q3 25 | $-57.1M | $8.6M | ||
| Q2 25 | $-34.7M | $14.7M | ||
| Q1 25 | $-45.6M | $10.3M | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | $-51.1M | $15.8M | ||
| Q2 24 | $-36.9M | $16.2M | ||
| Q1 24 | $-40.6M | $15.1M |
| Q4 25 | — | 26.4% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 32.4% | ||
| Q1 25 | — | 29.2% | ||
| Q4 24 | — | 27.3% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 33.6% |
| Q4 25 | -63.7% | 40.4% | ||
| Q3 25 | -851.8% | 33.7% | ||
| Q2 25 | -290.2% | 43.8% | ||
| Q1 25 | -1479.6% | 47.7% | ||
| Q4 24 | — | 42.3% | ||
| Q3 24 | -1439.4% | 50.8% | ||
| Q2 24 | -1276.2% | 50.6% | ||
| Q1 24 | -551.5% | 54.3% |
| Q4 25 | -19.9% | 32.2% | ||
| Q3 25 | -637.8% | 30.0% | ||
| Q2 25 | -203.3% | 38.3% | ||
| Q1 25 | -1077.2% | 42.3% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | -785.4% | 52.4% | ||
| Q2 24 | -504.3% | 51.1% | ||
| Q1 24 | -408.0% | 49.1% |
| Q4 25 | $-0.03 | $0.38 | ||
| Q3 25 | $-0.19 | $0.35 | ||
| Q2 25 | $-0.12 | $0.60 | ||
| Q1 25 | $-0.15 | $0.41 | ||
| Q4 24 | — | $0.59 | ||
| Q3 24 | $-0.17 | $0.64 | ||
| Q2 24 | $-0.13 | $0.65 | ||
| Q1 24 | $-0.14 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $8.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $528.6M |
| Total Assets | $1.4B | $580.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $8.5M | ||
| Q3 25 | $83.2M | $13.6M | ||
| Q2 25 | $92.4M | $2.6M | ||
| Q1 25 | $159.3M | $3.4M | ||
| Q4 24 | $156.3M | $1.1M | ||
| Q3 24 | $126.6M | $570.0K | ||
| Q2 24 | $148.3M | $60.0K | ||
| Q1 24 | $123.6M | $621.0K |
| Q4 25 | $966.9M | $528.6M | ||
| Q3 25 | $964.0M | $521.6M | ||
| Q2 25 | $1.0B | $512.8M | ||
| Q1 25 | $1.0B | $503.7M | ||
| Q4 24 | $1.1B | $494.0M | ||
| Q3 24 | $1.1B | $479.3M | ||
| Q2 24 | $1.1B | $463.2M | ||
| Q1 24 | $1.1B | $450.4M |
| Q4 25 | $1.4B | $580.3M | ||
| Q3 25 | $1.4B | $557.9M | ||
| Q2 25 | $1.4B | $552.0M | ||
| Q1 25 | $1.3B | $544.6M | ||
| Q4 24 | $1.4B | $534.2M | ||
| Q3 24 | $1.4B | $521.4M | ||
| Q2 24 | $1.4B | $514.9M | ||
| Q1 24 | $1.5B | $510.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $19.0M |
| Free Cash FlowOCF − Capex | $-44.6M | $15.7M |
| FCF MarginFCF / Revenue | -99.4% | 61.6% |
| Capex IntensityCapex / Revenue | 21.9% | 13.1% |
| Cash ConversionOCF / Net Profit | — | 2.32× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $28.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $19.0M | ||
| Q3 25 | $-52.6M | $7.2M | ||
| Q2 25 | $-32.4M | $6.1M | ||
| Q1 25 | $-11.6M | $4.9M | ||
| Q4 24 | $-108.6M | $7.9M | ||
| Q3 24 | $-28.9M | $13.8M | ||
| Q2 24 | $-30.0M | $3.5M | ||
| Q1 24 | $-41.7M | $10.8M |
| Q4 25 | $-44.6M | $15.7M | ||
| Q3 25 | $-61.5M | $5.1M | ||
| Q2 25 | $-45.8M | $3.7M | ||
| Q1 25 | $-22.2M | $3.6M | ||
| Q4 24 | $-187.0M | $6.0M | ||
| Q3 24 | $-47.4M | $9.1M | ||
| Q2 24 | $-50.1M | $1.7M | ||
| Q1 24 | $-65.8M | $9.9M |
| Q4 25 | -99.4% | 61.6% | ||
| Q3 25 | -687.0% | 17.8% | ||
| Q2 25 | -267.9% | 9.6% | ||
| Q1 25 | -524.0% | 15.0% | ||
| Q4 24 | -3702.8% | 16.4% | ||
| Q3 24 | -728.4% | 30.2% | ||
| Q2 24 | -683.8% | 5.4% | ||
| Q1 24 | -661.5% | 32.2% |
| Q4 25 | 21.9% | 13.1% | ||
| Q3 25 | 99.7% | 7.1% | ||
| Q2 25 | 78.2% | 6.2% | ||
| Q1 25 | 251.1% | 5.2% | ||
| Q4 24 | 1552.7% | 5.1% | ||
| Q3 24 | 284.6% | 15.6% | ||
| Q2 24 | 274.6% | 5.5% | ||
| Q1 24 | 242.5% | 2.8% |
| Q4 25 | — | 2.32× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |
